Search

Novocure Ltd

Cerrado

SectorSanidad

16.92 -2.48

Resumen

Variación precio

24h

Actual

Mínimo

16.64

Máximo

17.36

Métricas clave

By Trading Economics

Ingresos

55M

-16M

Ventas

9.5M

184M

BPA

-0.13

Margen de beneficios

-8.529

Empleados

1,605

EBITDA

53M

-11M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+74.04% upside

Dividendos

By Acuity

Próximas Ganancias

29 oct 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

169M

2B

Apertura anterior

19.4

Cierre anterior

16.92

Noticias sobre sentimiento de mercado

By Acuity

55%

45%

281 / 340 Clasificación en Healthcare

Novocure Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

14 ago 2026, 23:21 UTC

Novocure Ltd shares are higher in after-market trading, reversing a three-session decline. No specific company news was identified to explain this movement.

13 ago 2026, 21:01 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a shift in sentiment despite being above the 20-day moving average.

12 ago 2026, 19:41 UTC

Novocure Ltd. shares are lower today, reversing a trend of higher daily closes since Tuesday. Earlier in the session, the stock rebounded from a session high.

11 ago 2026, 20:06 UTC

Novocure Ltd's shares are advancing, remaining above the 20-day moving average amid strong momentum. No specific company news has been identified for the price movement.

10 ago 2026, 21:01 UTC

Novocure Ltd shares are higher in after-market trading, supported by strong performance above the 20-day moving average and within the one-month trading range.

8 ago 2026, 00:01 UTC

Novocure Ltd. shares were roughly flat in after-market hours. The stock is near the lower end of its one-month range, despite being above its 20-day average.

7 ago 2026, 23:11 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a decline since Friday's close and remaining near the lower end of their one-month range.

6 ago 2026, 19:36 UTC

Novocure Ltd. shares are trading lower, reaching a session low and remaining below the 20-day moving average during Thursday's trading session.

5 ago 2026, 19:56 UTC

Novocure Ltd. shares are lower today, trading below their 20-day moving average and near the lower end of their one-month range.

4 ago 2026, 21:02 UTC

Novocure Ltd. shares are lower in after-market trading, continuing a decline since Tuesday's close amid broader market volatility and fluctuating crude oil prices.

3 ago 2026, 20:06 UTC

Novocure Ltd. shares are higher today, reflecting broader market gains amid positive investor sentiment and declines in oil prices.

31 jul 2026, 19:46 UTC

Novocure Ltd. shares are lower today, retracing from earlier session highs amid rising bond yields and ongoing inflation concerns. The stock remains below its 20-day moving average.

30 jul 2026, 19:39 UTC

Novocure Ltd shares are higher today, recovering from an early dip. The stock remains below its 20-day moving average amid a trend of lower closes.

29 jul 2026, 18:55 UTC

Novocure Ltd's shares are declining today, reversing from a recent trend of higher daily closes. Earlier in the session, the stock briefly rebounded.

28 jul 2026, 23:31 UTC

Novocure Ltd. shares are lower in after-market hours, continuing a decline over the past four sessions and trading below the 20-day moving average.

27 jul 2026, 19:06 UTC

Novocure Ltd. shares are lower today amid a broader market decline influenced by a significant drop in crude oil prices.

24 jul 2026, 19:41 UTC

News
Social Media

Novocure Ltd's stock is lower following its Q2 earnings report, despite a narrower loss and revenue beat. Analysts lowered price targets amid ongoing investor concerns.

22 jul 2026, 20:04 UTC

Shares of Novocure Ltd. are lower today, continuing a decline since Tuesday's close amid broader market uncertainty ahead of the Federal Reserve meeting.

20 jul 2026, 14:36 UTC

Novocure Ltd. is trading higher since Friday's close, despite pulling back from an early session high amid broader market volatility from geopolitical tensions.

Comparación entre iguales

Cambio de precio

Novocure Ltd previsión

Precio Objetivo

By TipRanks

74.04% repunte

Estimación a 12 Meses

Media 29.5 USD  74.04%

Máximo 52 USD

Mínimo 17 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Novocure Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

281 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
help-icon Live chat